Who Supplies Insulin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Insulin exports, with 188+ registered manufacturers shipping to buyers across 111+ countries — yet a handful of companies dominate the shipments. WOCKHARDT LIMITED holds the largest share at 16.4% (export value: $12.5M). Close behind, M. J. BIOPHARM PRIVATE LIMITED (12.3%, $9.3M). M J BIOPHARM PRIVATE LIMITED (7.0%, $5.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Insulin? Top Manufacturers & Their Buyers
Flow of Insulin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Insulin Supplier Network — Key Market Intelligence
The Insulin export market from India is led by WOCKHARDT LIMITED, which alone commands a 16.4% share, shipping $12.5M worth of product across 454 shipments. The second-largest exporter, M. J. BIOPHARM PRIVATE LIMITED, contributes $9.3M (12.3%) to the overall market. Combined, the top two suppliers alone account for 28.7% of all Insulin exports, indicating a relatively concentrated supply base.
Across all 188 tracked manufacturers, the total Insulin export value stands at $76.0M from 2.5K shipments. The market average shipment value is $30.0K. The single largest buyer relationship in terms of trade value is BERLIN PHARMACEUTICALS INDUSTRY CO,, receiving $4.9M worth of product.
The combined buyer network spans 14 named purchasing companies, including BERLIN PHARMACEUTICALS INDUSTRY CO,, AYUSH PHARMA S A DE C V, PHARMARIS PERU S.A.C., SISTEMAS AEREOS SA DE, COMMERCIAL BANK OF ETHIOPIA and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1WOCKHARDT LIMITED
WOCKHARDT LIMITED is the first-largest Insulin exporter from India, with a market share of 16.4% and a total export value of $12.5M across 454 shipments. Their average shipment value of $27.5K is below the market average of $30.0K, reflecting a high-volume, competitive pricing strategy.
WOCKHARDT LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BERLIN PHARMACEUTICALS INDUSTRY CO, — $4.9M across 178 shipments (39.2% of this supplier's total exports)
• BERLIN PHARMACEUTICALS INDUSTRY CO, — $2.7M across 99 shipments (21.7% of this supplier's total exports)
• AYUSH PHARMA S A DE C V — $2.2M across 80 shipments (17.5% of this supplier's total exports)
• PHARMARIS PERU S.A.C. — $1.5M across 54 shipments (11.8% of this supplier's total exports)
• SISTEMAS AEREOS SA DE — $1.2M across 44 shipments (9.7% of this supplier's total exports)
Key Insight: WOCKHARDT LIMITED operates with high shipment frequency (454 shipments) at a per-shipment value of $27.5K, indicating a broad distribution network with many smaller, regular orders.
2M. J. BIOPHARM PRIVATE LIMITED
M. J. BIOPHARM PRIVATE LIMITED is the second-largest Insulin exporter from India, with a market share of 12.3% and a total export value of $9.3M across 303 shipments. Their average shipment value of $30.9K is above the market average of $30.0K, suggesting premium or bulk contract pricing.
M. J. BIOPHARM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• COMMERCIAL BANK OF ETHIOPIA — $3.0M across 98 shipments (32.5% of this supplier's total exports)
• BJC HEALTHCARE COMPANY LIMITED — $3.0M across 96 shipments (31.7% of this supplier's total exports)
• DIABETIKA SRL — $1.9M across 62 shipments (20.4% of this supplier's total exports)
• BANK OF CEYLON — $833.0K across 27 shipments (8.9% of this supplier's total exports)
• TOTHE MAURITIUS COMM — $609.3K across 20 shipments (6.5% of this supplier's total exports)
Key Insight: M. J. BIOPHARM PRIVATE LIMITED's per-shipment value of $30.9K is 3% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.
3M J BIOPHARM PRIVATE LIMITED
M J BIOPHARM PRIVATE LIMITED is the third-largest Insulin exporter from India, with a market share of 7.0% and a total export value of $5.3M across 75 shipments. Their average shipment value of $70.9K is above the market average of $30.0K, suggesting premium or bulk contract pricing.
M J BIOPHARM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• COMMERCIAL BANK OF ETHIOPIA — $1.9M across 26 shipments (35.2% of this supplier's total exports)
• BANK OF CEYLON — $1.2M across 17 shipments (22.9% of this supplier's total exports)
• BJC HEALTHCARE COMPANY LIMITED — $1.1M across 16 shipments (20.9% of this supplier's total exports)
• BIOCOM LIMITED — $628.2K across 9 shipments (11.8% of this supplier's total exports)
• DIABETIKA SRL — $489.7K across 7 shipments (9.2% of this supplier's total exports)
Key Insight: M J BIOPHARM PRIVATE LIMITED's per-shipment value of $70.9K is 136% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.
4GLAND PHARMA LTD
GLAND PHARMA LTD is the fourth-largest Insulin exporter from India, with a market share of 6.3% and a total export value of $4.8M across 81 shipments. Their average shipment value of $59.1K is above the market average of $30.0K, suggesting premium or bulk contract pricing.
GLAND PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ELI LILLY PAKISTAN (PRIVATE) LTD — $1.7M across 28 shipments (35.0% of this supplier's total exports)
• ELI LILLY PAKISTAN (PRIVATE) LTD — $1.6M across 26 shipments (32.6% of this supplier's total exports)
• LILLY KOREA LTD — $647.9K across 11 shipments (13.5% of this supplier's total exports)
• ELI LILLY PAKISTAN (PRIVATE) LTD — $477.4K across 8 shipments (10.0% of this supplier's total exports)
• ELI LILLY PAKISTAN (PRIVATE) LTD — $428.4K across 7 shipments (9.0% of this supplier's total exports)
Key Insight: GLAND PHARMA LTD's per-shipment value of $59.1K is 97% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.
5ORBIT LIFESCIENCE PVT. LTD.
ORBIT LIFESCIENCE PVT. LTD. is the fifth-largest Insulin exporter from India, with a market share of 2.2% and a total export value of $1.7M across 4 shipments. Their average shipment value of $420.1K is above the market average of $30.0K, suggesting premium or bulk contract pricing.
ORBIT LIFESCIENCE PVT. LTD. serves 1 named buyer in our database. INNODRIVE GROUP S.A DE CV is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• INNODRIVE GROUP S.A DE CV — $1.7M across 4 shipments (100.0% of this supplier's total exports)
Key Insight: ORBIT LIFESCIENCE PVT. LTD.'s per-shipment value of $420.1K is 1299% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.
6ANGEL BIOGENICS PRIVATE LIMITED
ANGEL BIOGENICS PRIVATE LIMITED is the fifth-largest Insulin exporter from India, with a market share of 1.4% and a total export value of $1.1M across 47 shipments. Their average shipment value of $22.8K is below the market average of $30.0K, reflecting a high-volume, competitive pricing strategy.
ANGEL BIOGENICS PRIVATE LIMITED serves 4 named buyers in our database. NA is the dominant customer, accounting for 60.8% of this supplier's tracked business. Top customers include:
• NA — $653.1K across 29 shipments (60.8% of this supplier's total exports)
• TO THE ORDER — $403.8K across 18 shipments (37.6% of this supplier's total exports)
• LILONGWE MALAWI — $16.0K across 1 shipments (1.5% of this supplier's total exports)
• To The Order — $1.0K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: ANGEL BIOGENICS PRIVATE LIMITED operates with high shipment frequency (47 shipments) at a per-shipment value of $22.8K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Insulin Flows
Once Insulin leaves the manufacturing plants of companies like WOCKHARDT LIMITED and M. J. BIOPHARM PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $76.0M. Thailand absorbs the largest share at 28.6% ($21.7M), followed by Mexico (19.2%) and Ethiopia (6.5%).
In Thailand — the top destination — named importers include BERLIN PHARMACEUTICALS INDUSTRY CO., BJC HEALTHCARE COMPANY LIMITED, BERLIN PHARMACEUTICALS INDUSTRY CO. In Mexico, key buyers are AYUSH PHARMA S.A DE C.V., AYUSH PHARMA S A DE C V, INNODRIVE GROUP S.A DE CV.
This geographic spread reflects Insulin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Insulin Go? Top Importing Countries & Their Buyers
Trade flow of Insulin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Thailand
Thailand ranks as the first-largest destination for Insulin imports from India, with a total trade value of $21.7M across 339 shipments — representing a 28.6% share of all Insulin exports. The average shipment value of $64.1K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Insulin importers in Thailand: BERLIN PHARMACEUTICALS INDUSTRY CO. is the largest buyer, accounting for 28.6% ($6.2M) of this market's total imports.
• BERLIN PHARMACEUTICALS INDUSTRY CO. — $6.2M (28.6% of Thailand's total)
• BJC HEALTHCARE COMPANY LIMITED — $6.1M (28.0% of Thailand's total)
• BERLIN PHARMACEUTICALS INDUSTRY CO — $5.2M (23.9% of Thailand's total)
Key Insight: Thailand's per-shipment average of $64.1K (114% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Insulin imports from India.
2Mexico
Mexico ranks as the second-largest destination for Insulin imports from India, with a total trade value of $14.6M across 31 shipments — representing a 19.2% share of all Insulin exports. The average shipment value of $472.0K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Insulin importers in Mexico: AYUSH PHARMA S.A DE C.V. is the largest buyer, accounting for 52.4% ($7.7M) of this market's total imports.
• AYUSH PHARMA S.A DE C.V. — $7.7M (52.4% of Mexico's total)
• AYUSH PHARMA S A DE C V — $2.2M (14.9% of Mexico's total)
• INNODRIVE GROUP S.A DE CV — $2.0M (13.9% of Mexico's total)
Key Insight: Mexico's per-shipment average of $472.0K (1472% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Insulin imports from India.
3Ethiopia
Ethiopia ranks as the third-largest destination for Insulin imports from India, with a total trade value of $5.0M across 13 shipments — representing a 6.5% share of all Insulin exports. The average shipment value of $382.2K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Insulin importers in Ethiopia: COMMERCIAL BANK OF ETHIOPIA is the largest buyer, accounting for 98.8% ($4.9M) of this market's total imports.
• COMMERCIAL BANK OF ETHIOPIA — $4.9M (98.8% of Ethiopia's total)
Key Insight: Ethiopia's per-shipment average of $382.2K (1173% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ethiopia is a key market for Insulin imports from India.
4Pakistan
Pakistan ranks as the fourth-largest destination for Insulin imports from India, with a total trade value of $4.5M across 59 shipments — representing a 6.0% share of all Insulin exports. The average shipment value of $77.1K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Insulin importers in Pakistan: ELI LILLY PAKISTAN (PVT ) LTD is the largest buyer, accounting for 36.8% ($1.7M) of this market's total imports.
• ELI LILLY PAKISTAN (PVT ) LTD — $1.7M (36.8% of Pakistan's total)
• ELI LILLY PAKISTAN (PRIVATE) LTD — $1.6M (34.3% of Pakistan's total)
Key Insight: Pakistan's per-shipment average of $77.1K (157% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Pakistan is a key market for Insulin imports from India.
5Dominican Republic
Dominican Republic ranks as the fifth-largest destination for Insulin imports from India, with a total trade value of $3.1M across 36 shipments — representing a 4.1% share of all Insulin exports. The average shipment value of $86.7K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Insulin importers in Dominican Republic: DIABETIKA SRL is the largest buyer, accounting for 76.7% ($2.4M) of this market's total imports.
• DIABETIKA SRL — $2.4M (76.7% of Dominican Republic's total)
Key Insight: Dominican Republic's per-shipment average of $86.7K (189% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Dominican Republic is a key market for Insulin imports from India.
People Also Ask — Insulin Supplier & Trade Network
Who are the top suppliers of Insulin from India?+
Which companies buy Insulin from Indian manufacturers?+
Where does Insulin exported from India go?+
What is the market share of the top Insulin supplier from India?+
What is the average shipment value for Insulin exports from India?+
Is Insulin manufactured in India and exported globally?+
Which country imports the most Insulin from India?+
Who are the buyers of Insulin in Mexico?+
How concentrated is the Insulin supplier market in India?+
How do I find verified buyers for Insulin in specific countries?+
Insulin Trade Network — Key Takeaways
- 1WOCKHARDT LIMITED is India's dominant Insulin exporter with a 16.4% market share and $12.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 188 suppliers collectively account for 45.6% of all tracked Insulin exports, with a combined trade value of $76.0M.
- 3Thailand is the largest destination market, absorbing 28.6% of India's Insulin exports ($21.7M). Mexico (19.2%) and Ethiopia (6.5%) follow.
- 4With 2.5K total shipments averaging $30.0K each, the Insulin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include BERLIN PHARMACEUTICALS INDUSTRY CO,, BERLIN PHARMACEUTICALS INDUSTRY CO,, COMMERCIAL BANK OF ETHIOPIA, BJC HEALTHCARE COMPANY LIMITED — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 111 countries
Network value: $76.0M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Insulin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Insulin.
- 2.Flow Mapping: 188 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,532 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 111 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,532 Verified Shipments
188 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists